Paloma Partners Management CO Sorrento Therapeutics, Inc. Transaction History

Paloma Partners Management CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.17 - $1.19 $641,750 - $4.49 Million	3,775,000 New	3,775,000 $1.36 Million
Q2 2022 Aug 15, 2022	SELL	$1.24 - $2.33 $59,012 - $110,887	-47,591 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.0 - $4.9 $95,182 - $233,195	47,591 New	47,591 $111,000
Q2 2019 Aug 14, 2019	SELL	$2.67 - $4.38 $102,261 - $167,754	-38,300 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$1.86 - $5.94 $44,640 - $142,560	24,000 Added 167.83%	38,300 $182,000
Q4 2018 Feb 14, 2019	BUY	$2.01 - $4.24 $28,742 - $60,632	14,300 New	14,300 $34,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.